Editor's key points † The long-term effect of esmolol and landiolol on neurological deficit and spatial memory was studied in rats. † Brain infarct was smaller at 28 days in treated rats. † Neurological score and spatial memory were not different at 28 days.
tings. We have previously reported that esmolol and landiolol ameliorated brain damage after transient focal ischaemia in rats. 1 2 Post-treatment, and pre-treatment, with b-antagonists resulted in brain protection for 7 days after transient focal 3 or global ischaemia. 5 However, it remains unknown whether neuroprotective effects would persist for 4 weeks after transient focal ischaemia. Spatial cognitive performance is known to be altered by pharmacological agents, ageing, and the environment. 12 -20 Middle cerebral artery occlusion (MCAO) affects memory acquisition such as avoidance task and maze task, 21 -24 and also spatial memory. 21 23 These results suggest that water maze can be used to assess memory disturbance after focal cerebral ischaemia. However, there are no reports of the effect of b-antagonists on the retention of spatial memory in the presence of transient focal ischaemia.
Therefore, we tested the hypothesis that b1-antagonists provide long-term neuroprotective effects and preserve spatial memory. We investigated the long-term effects of pre-treatment with selective b1-antagonists, esmolol and landiolol, on histological and behavioural outcomes after transient focal ischaemia in rats, and whether these b1-antagonists would affect the retention of spatial memory using the Morris water maze.
Methods
This study was approved by the Animal Subjects Committee of Akita University Graduate School of Medicine (approved number 1811).
(12 h light/12 h dark, 228C, 60% humidity) with free access to water. All the techniques used have been described previously. 1 2 In brief, after anaesthesia was induced with 4% halothane and 60% nitrous oxide in oxygen in an acrylic box, anaesthesia was maintained with 0.5-1.5% halothane in oxygen delivered by a mask during the study procedures. Skin incisions were performed after infiltration of a local anaesthetic. The end-tidal halothane concentration was maintained at 1.5% during the surgical procedure and decreased at 0.5% during MCAO. The right femoral artery was cannulated to measure arterial pressure and arterial blood gases. After the femoral vein was cannulated to infuse drugs, the catheter was tunnelled subcutaneously and exteriorized through a swivel sutured over the posterior mid-thorax to allow the rats to move freely in the cage after emergence from anaesthesia. Rectal and temporalis muscle temperatures were maintained with a heating pad and lamp throughout the experiment. The perfusion in the cortical area of the MCA was measured with laser-Doppler flowmetry (LDF) (Advance Laser Flowmeter ALF 21D; Advance, Tokyo, Japan). Transient focal cerebral ischaemia was induced by a modified technique for intraluminal MCAO as described previously. 1 -3 Briefly, the right common carotid artery was exposed and separated carefully from the vagus nerve and ligated at the more proximal side through a paramedian incision slightly to the right. The external carotid artery (ECA) was ligated at the more distal side and cut at the proximal side. The occipital artery of the ECA was coagulated. The pterygopalatine artery was ligated with a 5-0 silk suture. We induced ischaemia by advancing a diameter 0.32 mm monofilament nylon suture (Unique Medical, Tokyo, Japan), with its distal tip coated and rounded, into the internal carotid artery through the ECA until the LDF signal was significantly decreased. After placement, the intraluminal suture was then secured with a 5-0 silk suture tied around the ECA. After ischaemia for 90 min, reperfusion was induced by the withdrawal of the intraluminal suture. Rats were excluded from the study if the LDF signal did not decrease to below 40% of the baseline value or if restoration of the LDF signal did not occur at reperfusion. Twenty minutes after reperfusion and the wound was closed, rats were allowed to awake and were then returned to their cages.
Experimental groups
Rats were assigned to one of four groups with 10 surviving rats per group except the sham group. Rats received one of the following drugs i.v. 30 min before MCAO: saline 0. 
Behaviour and histological evaluation
Neurological examination was performed by an observer blinded to the treatment group, as described previously. 1 -3 Rats were evaluated using a neurological deficit score (Table 1) 1 at 4, 7, 11, 14, 18, 21, 25, and 28 days after reperfusion. Then, under deep halothane anaesthesia, an 18 G catheter was inserted through the apex of the left cardiac ventricle and advanced into the ascending aorta via a thoracotomy. The rat hearts were perfused with 100 ml heparinized 0.9% saline solution and then with 100 ml phosphate-buffered 10% formalin. To drain the perfused fluid, the right atrium was incised. Thereafter, the brain was removed and stored in the formalin solution and later embedded in paraffin. Next, 6 mm-thick coronal brain sections were stained with haematoxylin and eosin. The hippocampal subfields (length, 2.2 mm) and the striatum of both sides were evaluated in a coronal plane 3300 and 1000 mm posterior, respectively, to the bregma at ×200 magnification. The infarct lesion was measured by an observer blinded to treatment groups, using digital imaging (C-4040; Olympus, Tokyo, Japan) and image analysis software (SigmaScan Pro; Systat Software, Point Richmond, VA, USA). The infarct area was numerically integrated across each section and over the entire ipsilateral hemisphere. Infarct volumes were measured separately in the hippocampus and striatum and expressed as per cent infarct¼infarction/contralateral hemisphere×100.
Morris water-maze task
Spatial memory retention was examined using the Morris water maze as described previously. 21 25 The apparatus used was a 120 cm diameter cylindrical tank, filled with water, with a transparent 10 cm diameter platform placed at a constant position in the centre of one of the four quadrants. The platform was set 1 cm below the water level. Before transient focal ischaemia, acquisition trials were carried out four times a day for 7 successive days. In each two trials of four times, rats started to swim in the water from another two fixed starting positions. The time taken to reach onto the hidden platform and also the swimming path length were measured using a video image motion analyser (DVTrack DVT-11; Muromachi Kikai Co. Ltd, Tokyo, Japan). If rats did not reach the hidden platform in 90 s from the start of the swimming, they were placed onto the platform for 30 s during the acquisition trial. Post-ischaemia retention trials were carried out four times a day at 4, 7, 11, 14, 18, 21, 25, and 28 days after reperfusion, but in this case, rats failing to find the platform within 90 s were not placed onto the platform.
Statistical analyses
Data are presented as mean (SD), apart from neurological deficit scores which are given as median (range). The escape latency, swimming path length, swimming velocity, per cent time spent, number of crossings, per cent infarction, and physiological data among the treatment groups were analysed using Schaeffer's F-test as a post hoc test after one-way ANOVA. Neurological deficit scores were analysed using the Kruskal-Wallis test followed by the Wilcoxon test with Dunn's test. A P-value of ,0.05 was considered significant.
Results
Seven rats in the control group, five rats in the esmolol group, and four rats in the landiolol group died after MCAO, leaving 10 rats each in the control, the esmolol, and the landiolol groups, and four rats in the sham group.
Physiological variables
Basal arterial pressure, heart rate, arterial blood gas values, haemoglobin and blood glucose concentrations, and temperature (rectal and temporalis muscle) are shown in Table 2 , and variables did not differ between groups. The LDF signal decreased to ,40% of baseline in all the animals immediately after the onset of MCAO, remained unchanged during MCAO, and increased after reperfusion.
Neurological deficit scores
Neurological deficit scores in the landiolol-and esmololtreated rats were significantly lower than in control rats at 1, 4, 7, and 11 days after ischaemia. After 14 days, there were no significant differences in neurological deficit scores between groups (Table 3) .
Morris water-maze task
The escape latency, swimming path length, and swimming velocity to the hidden platform in pre-ischaemic trials and post-ischaemic acquisition trials are shown in Figure 1 . All the rats equally acquired this task before ischaemia. Escape latency to the platform was significantly shorter in the landiolol-treated rats compared with the saline-and esmolol-treated rats at 4, 7, and 14 days after ischaemia but not at later time points. The swimming path length was significantly less in the landiolol-treated rats compared with the esmolol-treated rats only at 4 days after ischaemia, and swimming velocity was similar in all groups at all time points. The percentage of time spent in the target quadrant, the percentage of time spent opposite the target quadrant, and the number of crossings in the study period are shown in Table 4 .
Infarction
Infarct volumes are shown in Figure 2 . The percentage infarction of the striatum and hippocampus in the landiolol-and esmolol-treated rats was significantly lower than in control rats at 28 days after ischaemia.
Discussion
In the present study, we have demonstrated that a continuous administration of landiolol or esmolol decreased the neurological deficit scores up to 14 days and infarct volumes up to 28 days after transient focal ischaemia in rats. Retention memory disturbance was attenuated only for 7 days by the administration of landiolol after transient focal ischaemia. According to our previous studies, selective b1-antagonists decreased neurological deficit scores and infarct volumes 7 days after transient focal ischaemia in rats, 1 2 and these neuroprotective effects were also evident even after post-ischaemic treatment with selective b1-antagonists. 3 Iwata and colleagues 5 also demonstrated that post-ischaemic treatment, but not pre-ischaemic treatment, with selective b1-antagonists decreased neural injury after transient forebrain ischaemia in rats. There are several reports demonstrating neuro-and cardioprotection with selective b1-antagonists, and mechanisms of these protective effects have been proposed. For example, selective b1-antagonists, esmolol and landiolol, suppressed glutamate concentrations in the striatum during focal ischaemia in rats, 2 while landiolol induced cardioprotective effects through its antioxidant activities in the ischaemicreperfused heart. 26 Further studies are needed to clarify more precisely the mechanisms of organ protection by selective b1-antagonists. The Morris water maze was originally developed for detecting deficits in hippocampally dependent cognitive functions, 23 since the hippocampus plays an important role in spatial memory retention. The Morris water-maze task was disturbed by not only forebrain ischaemia 27 but also by permanent focal ischaemia. 21 23 Since acquisition of the Morris water-maze task was impaired in rats with hippocampal lesions, and small parietal cortex lesions, 21 CA1 damage may not be the only determinant of the water-maze task. Rather, the impairment of the Morris water maze is Long-term and spatial memory effects by b-antagonists (8) 378 (10) Intra-ischaemia 465 (13) 437 (15) 453 (9) 395 (10)* Reperfusion 418 (8) 367 (8) 403 (6) 390 (12) (4) 125 (10) 114 (5) 108 (9) Intra-ischaemia 88 (2) 90 (5) 85 (4) 89 (9) Reperfusion 89 (3) 90 (5) 87 (4) 89 ( were measured at 4-28 days after ischaemia. The escape latency was lower in the landiolol-treated rats than the other two groups at 4, 7, and 14 days after ischaemia (P¼0.0022 at 4 days, P¼0.0017 at 7 days, and P¼0.0014 at 14 days). The swimming path length was less in the landiolol-treated rats than the esmolol-treated rats at 4 days after ischaemia (P¼0.0319). The swimming velocity was similar in all groups. Data are mean (SD); n¼10 in control, esmolol, and landiolol groups; n¼4 in the sham group.
suggested to be more likely related to cortical and/or caudate -putamen infarction. 21 However, different regions of the brain can contribute to cognitive procedures and memory retention, although the cortex, caudate -putamen, or both have a pivotal role. 15 25 28 Therefore, in this study, we used the Morris water maze to evaluate the spatial memory disturbance due to transient focal ischaemia. All the rats receiving ischaemic insults showed the prolongation of escape latency and path length compared with sham-operated rats, and these variables in the rats of the landiolol group were improved at 4, 7, and 14 days after MCAO. Further studies are needed to evaluate other aspects of cognitive function after focal ischaemia in the presence of b1-antagonists. We showed that the escape latency and path length in the landiolol-treated rats were shorter compared with the other rats, whereas no difference was found among groups in the velocity of swimming. The escape latency and path length were not different among the three groups after 14 days after ischaemia. These findings may be due to wide interindividual variations of the escape latency, the path length, and the acquirement of the task in the present study. Also, there was a possibility that these results might have been affected by the protocol used for the Morris water maze (number of trials per day, inter-trial interval, and duration of the acquisition period).
Infarct lesions were changed into the deficit parts by the absorption over a long time after the ischaemia. 29 -33 In this study, we compared the infarct lesion of the ipsilateral hemisphere with the same level of the contralateral hemisphere, because the infarct lesion of the ipsilateral hemisphere in the brain was changed into atrophy for a long term after the transient ischaemia in contrast to the contralateral hemisphere. 31 32 According to previous reports, 31 33 34 no improvement in neurological scores is seen 14 33 -36 and 28 days 31 after brain ischaemia. In the present study, neurological deficit scores were similar 14 days after ischaemia in all groups. Thus, there was a discrepancy between the neurological scores and the histological outcomes. This may be explained by different evaluation methods for neurological scores. We used the neurological score as described previously, 1 2 37 38 since this is a simple method to evaluate gait, behaviour, sensory, and motor function. In contrast, more detailed function was evaluated in other studies. 36 39 -42 The average weight of rats in the control group was less compared with the landiolol-and esmolol-treated rats due to poor weight gain after ischaemia in animals not receiving b-antagonists, as reported previously. 23 These results concur with the detrimental effects of focal ischaemia as shown by infarct size.
Limitations of the current study should be considered. We used only one dose of esmolol and landiolol. According to previous reports, there was dose -response in terms of neuroprotective effects of selective b1-antagonists for 7 days after focal ischaemia, 2 and we used a single dose as described previously. 1 3 Further studies are needed to evaluate the dose -response relationship of b1-antagonists in terms of the long-term cognitive and neurological functions after cerebral ischaemia. We used the Morris water maze to evaluate the spatial memory disturbance after 4 days, then every 3 or 4 days until 28 days after focal cerebral ischaemia. Repeated measurements may affect memory disturbance, because the rats would finally acquire this maze task even after ischaemia. In fact, there was no difference among groups in the escape latency, the path length, and the velocity of the last measurements in the current study.
In conclusion, we have demonstrated that the b1-antagonists, esmolol and landiolol, provided long-term neuroprotection in terms of histological outcome, but not neurological outcome spatial memory retention after transient focal ischaemia. Also, landiolol may be superior in terms of memory retention after focal ischaemia in rats, although the dose -response of these drugs was not evaluated in the present study.
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